Sports Minister launches Reference Material for anti-doping chemical testing synthesized by NDTL, NIPER
Advertisement
New Delhi: Union Minister of Youth Affairs and Sports Kiren Rijiju launched a breakthrough Reference Material for use in chemical testing in the field of anti-doping synthesized by collaborative efforts of the National Dope Testing Laboratory (NDTL) and National Institute of Pharmaceutical Education and Research (NIPER), Guwahati.
This Reference Material (RM), has been identified by NDTL as one of the rarely available RMs globally and would be used to strengthen anti-doping measures in all World Anti Doping Agency (WADA)-accredited laboratories. The Memorandum of Understanding (MoU) between NDTL and NIPER Guwahati was signed in August 2020 which proposes to synthesize 20 rarely available Reference Materials (RMs) during a period of 3 years. These RMs are used essentially during dope testing for quality control purposes and therefore their availability remains critical in sports dope testing, globally.
The availability of these RMs would help the anti-doping laboratories to strengthen their testing capacity. This will help in the greater cause of promoting fair play in sports.
"This is a special moment for all of us. The substance is small but the impact is big. Sportsmanship means clean sport and no cheating. I congratulate all the scientists in NDTL and NIPER-G for producing one of the 20 Reference Materials," said Rijiju.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.